InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: None

Thursday, 10/17/2013 10:08:21 AM

Thursday, October 17, 2013 10:08:21 AM

Post# of 429535
Had to step out at $2 and move on. Will still follow AMRN but from a personal standpoint did not like management was completely unprepared for a no, lack of guidance on where they are going etc...cannot sit around to see if they make good decisions.

Hopeful they get some kind of BP involvement but it was all about Anchor to me and anchor is gone. Now it is all about Reduce It, but that's possibly 4 years away. If they get there and its positive I will be back in. They Have to finish Reduce It, whatever it takes, no other options IMO and the fact they discussed the cost of it and reviewing whether to continue....it's your only asset, it's only value is in Reduce It results....everything should focus on, it should be "how do we get to Reduce It results still owning a solid 40-50% of Vascepa?"...simple to me Reduce it or bust! And in reality it is Reduce It or Bust in every way.

Where it was all about Anchor and that failed it's now all about Reduce It--I was willing to wait until Anchor, but not waiting 4 years for Reduce It.

I will still check in on AMRN and on my watch-list always but learned a lot about biotech's and WS, I still have minimum 10 years(maybe 20) before I need to take my retirement money and make it last, this AMRN experience will be helpful when I get to that point, glad I had the experience, wish it worked out differently.

In the end because of AMRN research I started taking Plusepa for preventative, may some day get on Vascepa for preventative measures, for all I know this AMRN adventure has turned me onto EPA and will add many years to my life, not a bad trade off if so.

For those going to ride out the storm and to new speculators, best of luck.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News